Ni Jun - Net Worth and Insider Trading
Ni Jun Net Worth
The estimated net worth of Ni Jun is at least $363,600 dollars as of 2025-04-13. Ni Jun is the senior management of China Resources Double-Crane Pharmaceutical Co Ltd and owns about 20,000 shares of China Resources Double-Crane Pharmaceutical Co Ltd (SHSE:600062) stock worth over $363,600. Details can be seen in Ni Jun's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Ni Jun has not made any transactions after 2021-03-23 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Ni Jun
Ni Jun Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Ni Jun owns 1 companies in total, including China Resources Double-Crane Pharmaceutical Co Ltd (SHSE:600062) .
Click here to see the complete history of Ni Jun’s form 4 insider trades.
Insider Ownership Summary of Ni Jun
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SHSE:600062 | China Resources Double-Crane Pharmaceutical Co Ltd | 2021-03-23 | senior management |
Ni Jun Latest Holdings Summary
Ni Jun currently owns a total of 1 stock. Ni Jun owns 20,000 shares of China Resources Double-Crane Pharmaceutical Co Ltd (SHSE:600062) as of March 23, 2021, with a value of $363,600.
Latest Holdings of Ni Jun
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SHSE:600062 | China Resources Double-Crane Pharmaceutical Co Ltd | 2021-03-23 | 20,000 | 18.18 | 363,600 |
Holding Weightings of Ni Jun
Ni Jun Form 4 Trading Tracker
According to the SEC Form 4 filings, Ni Jun has made a total of 2 transactions in China Resources Double-Crane Pharmaceutical Co Ltd (SHSE:600062) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in China Resources Double-Crane Pharmaceutical Co Ltd is the acquisition of 10,000 shares on March 23, 2021, which cost Ni Jun around $119,100.
Insider Trading History of Ni Jun
- 1
Ni Jun Trading Performance
GuruFocus tracks the stock performance after each of Ni Jun's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Ni Jun is -2.01%. GuruFocus also compares Ni Jun's trading performance to market benchmark return within the same time period. The performance of stocks bought by Ni Jun within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Ni Jun's insider trading performs compared to the benchmark.
Performance of Ni Jun
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -0.63 | | | | | |
| Relative Return to S&P 500(%) | -6.54 | | | | | |
Ni Jun Ownership Network
Ownership Network List of Ni Jun
Ownership Network Relation of Ni Jun
Ni Jun Owned Company Details
What does China Resources Double-Crane Pharmaceutical Co Ltd do?
Who are the key executives at China Resources Double-Crane Pharmaceutical Co Ltd?
Ni Jun is the senior management of China Resources Double-Crane Pharmaceutical Co Ltd. Other key executives at China Resources Double-Crane Pharmaceutical Co Ltd include senior management han shuo , senior management Liu Zi Qin , and senior management Fan Yan Xi .
China Resources Double-Crane Pharmaceutical Co Ltd (SHSE:600062) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of China Resources Double-Crane Pharmaceutical Co Ltd (SHSE:600062) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of China Resources Double-Crane Pharmaceutical Co Ltd (SHSE:600062) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
China Resources Double-Crane Pharmaceutical Co Ltd (SHSE:600062)'s detailed insider trading history can be found in Insider Trading Tracker table.
China Resources Double-Crane Pharmaceutical Co Ltd Insider Transactions
Ni Jun Mailing Address
Above is the net worth, insider trading, and ownership report for Ni Jun. Currently GuruFocus does not have mailing address information for Ni Jun.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
